Discussing Pivotal Progress in Breast Cancer in Dallas

We recently traveled to Dallas, Texas, for a State of the Science Summit on Breast Cancer. During the meeting, faculty from Baylor Scott and White Health System and The University of Texas MD Anderson Cancer Center relayed the prognostic value of genomic assays in breast cancer and the scope of established and ensuing treatment approaches for those with early-stage and advanced disease.